应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09966 康宁杰瑞制药-B
国庆日休市 09-30 16:08:27
8.450
+0.400
+4.97%
最高
8.490
最低
8.100
成交量
143.30万
今开
8.100
昨收
8.050
日振幅
4.84%
总市值
81.71亿
流通市值
81.71亿
总股本
9.67亿
成交额
1,201万
换手率
0.15%
流通股本
9.67亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康宁杰瑞制药-B:2026年9月28日回购5.8万股,涉资约46.49万港元
公告速递 · 09-28 19:26
康宁杰瑞制药-B:2026年9月28日回购5.8万股,涉资约46.49万港元
康宁杰瑞制药-B(09966)9月28日斥资46.5万港元回购5.8万股
智通财经 · 09-28 19:25
康宁杰瑞制药-B(09966)9月28日斥资46.5万港元回购5.8万股
康宁杰瑞制药-B(09966)9月25日斥资29.03万港元回购3.5万股
智通财经网 · 09-25
康宁杰瑞制药-B(09966)9月25日斥资29.03万港元回购3.5万股
康宁杰瑞制药-B9月25日回购3.50万股,耗资约29.03万港元
公告速递 · 09-25
康宁杰瑞制药-B9月25日回购3.50万股,耗资约29.03万港元
康宁杰瑞制药-B2026年中期营收2.71亿元
公告速递 · 09-24
康宁杰瑞制药-B2026年中期营收2.71亿元
创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%
老虎资讯综合 · 09-23
创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%
康宁杰瑞制药-B于9月22日回购6万股,耗资约48.65万港元
公告速递 · 09-22
康宁杰瑞制药-B于9月22日回购6万股,耗资约48.65万港元
康宁杰瑞制药-B(09966.HK)9月22日斥资48.65万港元回购6万股
智通财经 · 09-22
康宁杰瑞制药-B(09966.HK)9月22日斥资48.65万港元回购6万股
康宁杰瑞制药-B回购12.40万股股份,耗资约95.03万港元
公告速递 · 09-18
康宁杰瑞制药-B回购12.40万股股份,耗资约95.03万港元
康宁杰瑞制药-B(09966.HK)9月18日斥资95.03万港元回购12.4万股
智通财经 · 09-18
康宁杰瑞制药-B(09966.HK)9月18日斥资95.03万港元回购12.4万股
康宁杰瑞制药-B:9月17日回购12.40万股,耗资约96.31万港元
公告速递 · 09-17
康宁杰瑞制药-B:9月17日回购12.40万股,耗资约96.31万港元
康宁杰瑞制药-B(09966.HK)9月17日斥资96.31万港元回购12.4万股
智通财经 · 09-17
康宁杰瑞制药-B(09966.HK)9月17日斥资96.31万港元回购12.4万股
康宁杰瑞制药-B回购6.2万股股份,耗资约47.83万港元
公告速递 · 09-16
康宁杰瑞制药-B回购6.2万股股份,耗资约47.83万港元
康宁杰瑞制药-B:9月15日回购12.2万股,耗资约96.73万港元
公告速递 · 09-15
康宁杰瑞制药-B:9月15日回购12.2万股,耗资约96.73万港元
康宁杰瑞制药-B(09966)9月15日斥资96.7万港元回购12.2万股
智通财经 · 09-15
康宁杰瑞制药-B(09966)9月15日斥资96.7万港元回购12.2万股
康宁杰瑞制药-B 9月14日回购9.9万股,耗资约79.63万港元
公告速递 · 09-14
康宁杰瑞制药-B 9月14日回购9.9万股,耗资约79.63万港元
康宁杰瑞制药-B(09966)9月14日耗资约79.63万港元回购9.9万股
智通财经 · 09-14
康宁杰瑞制药-B(09966)9月14日耗资约79.63万港元回购9.9万股
康宁杰瑞制药-B 9月11日回购12.3万股股份,总额约97.75万港元
公告速递 · 09-11
康宁杰瑞制药-B 9月11日回购12.3万股股份,总额约97.75万港元
康宁杰瑞制药-B(09966.HK)9月11日斥资约97.75万港元回购12.3万股
智通财经 · 09-11
康宁杰瑞制药-B(09966.HK)9月11日斥资约97.75万港元回购12.3万股
康宁杰瑞制药-B 9月10日回购16.4万股,涉资约135.76万港元
公告速递 · 09-10
康宁杰瑞制药-B 9月10日回购16.4万股,涉资约135.76万港元
加载更多
公司概况
公司名称:
康宁杰瑞制药-B
所属市场:
SEHK
上市日期:
--
主营业务:
康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司的内部管线由处于不同研发阶段的抗体偶联药物(ADC)、单克隆抗体及双特异性抗体肿瘤药物组成。该公司的产品管线包括KN046(PD-L1/CTLA-4双特异性抗体)、KN026(抗HER2双特异性抗体)、KN035(皮下注射PD-L1)、JSKN003(HER2双表位ADC)、JSKN016(HER3/TROP2双特异性抗体ADC)、JSKN033(JSKN003和KN035 的皮下复方制剂)等,用于1L sq NSCLC、1L HER2+乳腺癌、1L胆道癌、晚期实体瘤、HER2表达实体瘤等适应症。
发行价格:
--
{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":8.45,"timestamp":1790755707010,"preClose":8.05,"halted":0,"volume":1433000,"delay":0,"changeRate":0.049689440993788636,"floatShares":967000000,"shares":967000000,"eps":-0.14034697864927848,"marketStatus":"国庆日休市","change":0.4,"latestTime":"09-30 16:08:27","open":8.1,"high":8.49,"low":8.1,"amount":12013865,"amplitude":0.048447,"askPrice":8.465,"askSize":12000,"bidPrice":8.45,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.21334729003554526,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":8.05,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.637431,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"1152900967","title":"康宁杰瑞制药-B:2026年9月28日回购5.8万股,涉资约46.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152900967","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152900967?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:26","pubTimestamp":1790594780,"startTime":"0","endTime":"0","summary":"2026年9月28日,康宁杰瑞制药-B(09966)公告称,公司于当日在香港联交所场内回购普通股5.8万股,约占回购前已发行股本的0.006%。本次回购价格区间介乎每股港币7.99元至8.06元,合计耗资约46.49万港元。\n回购完成后,公司已发行股本由原先的9.66634697亿股减少至9.66576697亿股,同时库存股数增至780.5万股。公司于2026年6月12日通过购回授权,总额度为9685.0669万股,截至目前已累计回购193万股,占该购回授权通过当日已发行股本的0.1993%。\n公司确认本次股份购回符合香港联交所证券上市规则及相关法例。公告由执行董事徐霆签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B:2026年9月28日回购5.8万股,涉资约46.49万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670231222","title":"康宁杰瑞制药-B(09966)9月28日斥资46.5万港元回购5.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670231222","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670231222?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:25","pubTimestamp":1790594735,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)发布公告,于2026年9月28日斥资46.5万港元回购5.8万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440905","title":"康宁杰瑞制药-B(09966)9月25日斥资29.03万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440905","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670440905?lang=zh_cn&edition=full","pubTime":"2026-09-25 20:44","pubTimestamp":1790340265,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)发布公告,该公司于2026年9月25日斥资29.03万港元回购3.5万股股份,每股回购价格为8.2-8.34港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122218913","title":"康宁杰瑞制药-B9月25日回购3.50万股,耗资约29.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122218913","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122218913?lang=zh_cn&edition=full","pubTime":"2026-09-25 20:26","pubTimestamp":1790339172,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月25日发布翌日报表,宣布当日在香港联交所场内回购普通股3.50万股,回购价格区间为每股8.20港元至8.34港元,总耗资约29.03万港元。本次回购股份数量占该公司回购前已发行股本的约0.0036%。根据公告,回购股份事宜已于2026年6月12日经股东大会通过购回授权,发行人可根据该授权回购股份的总数为96,850,669股,截至目前,公司已累计回购1,872,000股。公司确认该项回购符合香港联合交易所有限公司的上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B9月25日回购3.50万股,耗资约29.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109151735","title":"康宁杰瑞制药-B2026年中期营收2.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109151735","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109151735?lang=zh_cn&edition=full","pubTime":"2026-09-24 21:43","pubTimestamp":1790257416,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B发布2026年中期报告,营收录得2.71亿元人民币,同比下降约15%。报告期内毛利约2.45亿元,毛利率达到90.28%,与上年同期基本持平。经营活动现金流出现净流出0.61亿元,上年同期净流出约0.02亿元。销售及管理费用率略有下降,销售及管理费用约0.34亿元,同比降幅约1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康宁杰瑞制药-B2026年中期营收2.71亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188227323","title":"创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188227323","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188227323?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:01","pubTimestamp":1790132509,"startTime":"0","endTime":"0","summary":"9月23日,创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%,康方生物、诺诚健华涨逾3%,基石药业涨逾2%,百济神州、药明生物、君实生物涨逾1%,信达生物跟涨。9月12-15日2026年世界肺癌大会召开,多项中国创新药临床数据集中亮相,康方生物依沃西单药OS数据、B7H3 ADC等成为焦点;与此同时,2026年国家医保目录谈判收官,商保创新药目录同步推进,支付端改革预期升温,\"出海商业化+支付改善\"的产业逻辑持续强化。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","01672","02137","02269","03347","03759","09688","09995","01801","06606","06996","02359","02268","09606","09966","06618","06978","00241"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1119094665","title":"康宁杰瑞制药-B于9月22日回购6万股,耗资约48.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119094665","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119094665?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:32","pubTimestamp":1790076757,"startTime":"0","endTime":"0","summary":"2026年9月22日,康宁杰瑞制药-B在香港联合交易所发布翌日披露报表,宣布于当日以场内方式回购普通股合共60,000股,占回购日前已发行股份总数的约0.0062%。本次回购价格区间介于每股8.095港元至8.12港元,总耗资约48.65万港元。回购完成后,公司已发行股份数量为966,669,697股,库存股为7,712,000股,总发行股份数维持在974,381,697股。根据公告,公司已于2026年6月12日获得股东通过股份购回授权,可回购股份总数为96,850,669股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B于9月22日回购6万股,耗资约48.65万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669491191","title":"康宁杰瑞制药-B(09966.HK)9月22日斥资48.65万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669491191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669491191?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:30","pubTimestamp":1790076621,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125550836","title":"康宁杰瑞制药-B回购12.40万股股份,耗资约95.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125550836","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125550836?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:02","pubTimestamp":1789732926,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月18日发布公告,披露当日于香港联交所场内回购公司股份12.40万股,占该公司回购前已发行股本约0.0128%。回购价格介乎每股7.625港元至7.70港元,总计耗资约95.03万港元。公告显示,回购完成后,公司已发行股份总数变动至966,729,697股,库藏股数量升至7,652,000股。公司确认有关回购行为符合香港联交所证券上市规则及相关法规的规定。本次公告由执行董事徐霆签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购12.40万股股份,耗资约95.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668792395","title":"康宁杰瑞制药-B(09966.HK)9月18日斥资95.03万港元回购12.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668792395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668792395?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:01","pubTimestamp":1789732918,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176781780","title":"康宁杰瑞制药-B:9月17日回购12.40万股,耗资约96.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176781780","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176781780?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:06","pubTimestamp":1789643175,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月17日发布公告称,当日公司在香港联交所场内回购普通股124,000股,占当日回购前已发行股本的约0.0128%。本次回购每股价格介乎7.68港元至7.87港元,总金额约96.31万港元。此前于2026年6月12日,公司相关购回授权已获股东大会批准,可回购股份的总数为96,850,669股,截至目前累计已回购1,653,000股。公司确认,本次回购行为已遵守香港联交所证券上市规则及相关法规。上述公告由执行董事徐霆签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B:9月17日回购12.40万股,耗资约96.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668694219","title":"康宁杰瑞制药-B(09966.HK)9月17日斥资96.31万港元回购12.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668694219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668694219?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:06","pubTimestamp":1789643165,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165881447","title":"康宁杰瑞制药-B回购6.2万股股份,耗资约47.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165881447","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165881447?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:42","pubTimestamp":1789555338,"startTime":"0","endTime":"0","summary":"2026年9月16日,康宁杰瑞制药-B发布翌日披露报表,披露了最新的股份回购情况。根据公告,康宁杰瑞制药-B于2026年9月16日在香港联交所场内回购普通股6.2万股,占回购前已发行股本约0.0064%。回购价格介乎每股7.70港元至7.73港元,总耗资47.83万港元。回购完成后,公司已发行股本由9.67039697亿股降至9.66977697亿股,同时库藏股数量由734.2万股增至740.4万股。本次回购依据公司于2026年6月12日获得的购回授权进行,该授权最高可回购9,685.0669万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B回购6.2万股股份,耗资约47.83万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185229625","title":"康宁杰瑞制药-B:9月15日回购12.2万股,耗资约96.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185229625","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185229625?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:45","pubTimestamp":1789472755,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(09966)于2026年9月15日发布翌日披露报表,披露于香港联交所场内回购普通股122,000股,约占该日前已发行股本(不含库藏股)0.0126%。每股回购价格介乎7.895港元至8.005港元,总金额约96.73万港元。\n回购完成后,公司已发行股本(不含库藏股)为967,039,697股,库藏股数增至7,342,000股。根据公告,购回授权于2026年6月12日获股东大会批准,公司此前已通过该授权累计回购1,467,000股。公司确认已遵守香港联交所证券上市规则及相关法律法规。\n本公告由执行董事徐霆签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B:9月15日回购12.2万股,耗资约96.73万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644517","title":"康宁杰瑞制药-B(09966)9月15日斥资96.7万港元回购12.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644517","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667644517?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:44","pubTimestamp":1789472658,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)发布公告,于2026年9月15日斥资96.7万港元回购12.2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177986791","title":"康宁杰瑞制药-B 9月14日回购9.9万股,耗资约79.63万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177986791","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177986791?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:25","pubTimestamp":1789385143,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月14日公告进行股份回购,涉及数量99,000股,占当日回购前已发行股本约0.0102%。回购价格区间介乎每股7.935港元至8.075港元,合计支付约79.63万港元。公告显示,本次回购后公司已发行股本由9月11日的967,260,697股下降至967,161,697股,库藏股数量则由7,121,000股上升至7,220,000股,总已发行股本维持在974,381,697股。根据2026年6月12日通过的回购授权,公司可回购的股份总数为96,850,669股,目前已于包括本次在内的几次回购中累计回购1,345,000股,占授权通过日已发行股本的0.1389%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B 9月14日回购9.9万股,耗资约79.63万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667469668","title":"康宁杰瑞制药-B(09966)9月14日耗资约79.63万港元回购9.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667469668","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667469668?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:23","pubTimestamp":1789384984,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)公布,2026年9月14日耗资约79.63万港元回购9.9万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158940823","title":"康宁杰瑞制药-B 9月11日回购12.3万股股份,总额约97.75万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158940823","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158940823?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:16","pubTimestamp":1789121801,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B于2026年9月11日发布翌日报表。公告显示,公司当日于香港联交所场内回购普通股123,000股,约占回购前现有已发行股份总数的0.0127%,回购价格介乎每股7.85港元至8.00港元,合计耗资约97.75万港元。本次回购完成后,公司已发行股份数量为967,260,697股,库藏股数上升至7,121,000股,合计已发行股份总数仍为974,381,697股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B 9月11日回购12.3万股股份,总额约97.75万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525574","title":"康宁杰瑞制药-B(09966.HK)9月11日斥资约97.75万港元回购12.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525574","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666525574?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:14","pubTimestamp":1789121672,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121214818","title":"康宁杰瑞制药-B 9月10日回购16.4万股,涉资约135.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121214818","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121214818?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:47","pubTimestamp":1789037232,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B在2026年9月10日发布公告,披露于同日通过香港联交所场内回购股份16.4万股,约占已发行股本的0.017%。本次回购最高价为每股港币8.325元,最低价为每股港币8.165元,总涉资港币1,357,620元。回购完成后,公司已发行股本由回购前的967,547,697股降至967,383,697股,库存股数量增至6,998,000股,公司已发行股份总数仍为974,381,697股。截至目前,公司已累计回购1,123,000股,占当日购回授权通过时已发行股本的约0.116%。本次公告由执行董事徐霆签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B 9月10日回购16.4万股,涉资约135.76万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":-0.0574},{"period":"3month","weight":0.1575},{"period":"6month","weight":-0.0653},{"period":"1year","weight":-0.3832},{"period":"ytd","weight":-0.1378}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0676},{"period":"6month","weight":-0.02},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司的内部管线由处于不同研发阶段的抗体偶联药物(ADC)、单克隆抗体及双特异性抗体肿瘤药物组成。该公司的产品管线包括KN046(PD-L1/CTLA-4双特异性抗体)、KN026(抗HER2双特异性抗体)、KN035(皮下注射PD-L1)、JSKN003(HER2双表位ADC)、JSKN016(HER3/TROP2双特异性抗体ADC)、JSKN033(JSKN003和KN035 的皮下复方制剂)等,用于1L sq NSCLC、1L HER2+乳腺癌、1L胆道癌、晚期实体瘤、HER2表达实体瘤等适应症。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.117313},{"month":2,"riseRate":0.571429,"avgChangeRate":0.192959},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.039472},{"month":4,"riseRate":0.857143,"avgChangeRate":0.098183},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.031094},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.059361},{"month":7,"riseRate":0.428571,"avgChangeRate":0.061567},{"month":8,"riseRate":0.428571,"avgChangeRate":0.047929},{"month":9,"riseRate":0.285714,"avgChangeRate":0.127495},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.030396},{"month":11,"riseRate":0.5,"avgChangeRate":0.042537},{"month":12,"riseRate":0.5,"avgChangeRate":-0.017716}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}